| __timestamp | Dynavax Technologies Corporation | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 1288519000 |
| Thursday, January 1, 2015 | 4050000 | 1465761000 |
| Friday, January 1, 2016 | 11043000 | 1598800000 |
| Sunday, January 1, 2017 | 327000 | 1725300000 |
| Monday, January 1, 2018 | 8198000 | 1627800000 |
| Tuesday, January 1, 2019 | 35219000 | 1448800000 |
| Wednesday, January 1, 2020 | 46551000 | 1483300000 |
| Friday, January 1, 2021 | 439442000 | 1685500000 |
| Saturday, January 1, 2022 | 722683000 | 1936300000 |
| Sunday, January 1, 2023 | 232284000 | 2327500000 |
In pursuit of knowledge
In the competitive world of biotechnology, revenue growth is a key indicator of success. United Therapeutics Corporation and Dynavax Technologies Corporation have been on divergent paths over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed Dynavax, with revenues peaking at approximately $2.3 billion in 2023, marking an 80% increase from 2014. In contrast, Dynavax's revenue journey was more volatile, with a significant leap in 2022, reaching around $723 million, a staggering 6,500% increase from its 2014 figures. This dramatic rise highlights Dynavax's potential to disrupt the market, despite its smaller scale compared to United Therapeutics. The data underscores the dynamic nature of the biotech industry, where strategic innovation and market adaptation can lead to rapid growth. As these companies continue to evolve, investors and industry watchers will be keenly observing their next moves.
Revenue Insights: Zoetis Inc. and United Therapeutics Corporation Performance Compared
Biogen Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
United Therapeutics Corporation and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Comparing Revenue Performance: Bausch Health Companies Inc. or Dynavax Technologies Corporation?
Revenue Insights: Dynavax Technologies Corporation and MiMedx Group, Inc. Performance Compared